VMedKit

Democratizing mental healthcare through VR

Epitaph

“Here lies VMedKit. It brought VR exposure therapy to Nigerian clinics, treating PTSD, phobias and anxiety on Oculus headsets. Costly hardware, a shortage of localized 3D content, and slow uptake among VR-trained clinicians held it back, and after its 2019 high point it faded from view.”

Overview

Born: 2018 (Year)
Died: June 2021 (Month)
Lifespan: 3 years
Fate: Shut down
Headquarters: 🇳🇬 Nigeria
Category: Health Tech
Stage at death: Grant or Pre-Seed
Primary cause: Business model or unit economics
Contributing causes: Infrastructure dependency, Distribution or go-to-market

Death certificate

Timeline

2018Founding
Emmanuel Okon and co-founders (Philip Igboba, Feyisetan Oluwatoyosi, Jimoh Saheed, Ridwan Yusuf) launch VMedKit in Lagos
2019Facebook backing
Facebook invests $20,000 and supplies Oculus headsets
2019Recognition
Okon named a finalist for the Anzisha Prize
June 2021Reported shutdown
Listed as shut down in existing dataset, citing hardware costs and slow clinical adoption

Autopsy report

Why did VMedKit shut down?

VMedKit was a Lagos social enterprise using VR Exposure Therapy (Oculus headsets) to treat PTSD, phobias and anxiety, targeting hospitals and clinics on a B2B basis. Independent research found no dedicated shutdown article beyond the existing dataset's account; available evidence only confirms the venture's 2018-2019 growth phase, not the circumstances of its later closure.

What VMedKit attempted

VMedKit built VR Exposure Therapy (VRET) tools on Oculus headsets to treat PTSD, phobias and anxiety, aiming at hospitals, clinics, autism centers and workplaces to democratize access to immersive psychotherapy in Nigeria.

What worked

By late 2019 it reported having helped 500+ people, with clients including three hospitals and an autism center; received a $20,000 investment and Oculus headsets from Facebook, plus recognition from the Tony Elumelu Foundation, and founder Emmanuel Okon was a 2019 Anzisha Prize finalist.

What happened

Unknown — no sourced account of the shutdown sequence was found beyond the dataset's existing narrative citing high Oculus headset costs, lack of localized 3D content, and slow B2B adoption due to few VR-trained clinical psychologists.

Lessons for future builders

Selling costly VR therapy to hospitals stalls when few clinicians can run the kit and clinic budgets are thin. Prove a handful of sites will pay and staff can deliver before betting on immersive hardware at scale.